For years digital health platforms have been integral in helping navigate viral outbreaks such as HIV, COVID-19, and monkeypox. Ramin Bastani, CEO of Healthvana – a platform that delivers test results and records (the company just surpassed 50 million records delivered) to get patients on the right track to receive treatment – talks about how such digital health solutions are improving the response to disease outbreaks.
Using a special desktop camera, AEYE takes images from each eye and through artificial intelligence it captures and analyzes data of the retina that helps diagnose diseases, including diabetes, that could lead to blindness.
Elevalt’s 4Ps proprietary algorithms are the culmination of six years of refining omnichannel execution and are the foundation of the company’s data-driven approach to commercialization.
Thanks to the meteoric rise of digital health, the role of data and analytics has also become central across the drug development life cycle, impacting every touch point from pipeline research and development to clinical trial design and implementation. A critical area that has fallen short, however, is applying a commensurate level of enthusiasm and expense for market research in the early phase as that afforded to downstream commercialization efforts. Compounding this challenge is the continued marginalization of disenfranchised communities.